AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $13,947,000 | +57.5% | 233,067 | -26.1% | 7.82% | +131.1% |
| Q3 2019 | $8,858,000 | -25.8% | 315,331 | 0.0% | 3.38% | -13.6% |
| Q2 2019 | $11,938,000 | -3.0% | 315,331 | 0.0% | 3.92% | +22.2% |
| Q1 2019 | $12,304,000 | +83.0% | 315,331 | 0.0% | 3.20% | +45.1% |
| Q4 2018 | $6,723,000 | -46.1% | 315,331 | 0.0% | 2.21% | -19.9% |
| Q3 2018 | $12,484,000 | +3.6% | 315,331 | 0.0% | 2.76% | +6.2% |
| Q2 2018 | $12,049,000 | +27.2% | 315,331 | 0.0% | 2.60% | +25.7% |
| Q1 2018 | $9,476,000 | +735.6% | 315,331 | +373.8% | 2.06% | +374.7% |
| Q1 2017 | $1,134,000 | -6.7% | 66,553 | 0.0% | 0.44% | -17.6% |
| Q4 2016 | $1,216,000 | +2.6% | 66,553 | 0.0% | 0.53% | -4.7% |
| Q3 2016 | $1,185,000 | – | 66,553 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |